Association Between 21-Gene Assay Recurrence Score and Locoregional Recurrence Rates in Patients With Node-Positive Breast Cancer

IMPORTANCE: The 21-gene assay recurrence score is increasingly used to personalize treatment recommendations for systemic therapy in postmenopausal women with estrogen receptor (ER)– or progesterone receptor (PR)–positive, node-positive breast cancer; however, the relevance of the 21-gene assay to r...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:JAMA Oncol
Autori principali: Woodward, Wendy A., Barlow, William E., Jagsi, Reshma, Buchholz, Thomas A., Shak, Steven, Baehner, Frederick, Whelan, Timothy J., Davidson, Nancy E., Ingle, James N., King, Tari A., Ravdin, Peter M., Osborne, C. Kent, Tripathy, Debasish, Livingston, Robert B., Gralow, Julie R., Hortobagyi, Gabriel N., Hayes, Daniel F., Albain, Kathy S.
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Medical Association 2020
Soggetti:
Original Investigation
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6990911/
https://ncbi.nlm.nih.gov/pubmed/31917424
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaoncol.2019.5559
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi